TY - DATA T1 - Additional file 6: Figure S5. of Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer PY - 2017/11/15 AU - Jia-Qi Wu AU - Jing Zhai AU - Chong-Yong Li AU - Ai-Min Tan AU - Ping Wei AU - Li-Zong Shen AU - Ming-Fang He UR - https://springernature.figshare.com/articles/figure/Additional_file_6_Figure_S5_of_Patient-derived_xenograft_in_zebrafish_embryos_a_new_platform_for_translational_research_in_gastric_cancer/5606284 DO - 10.6084/m9.figshare.c.3931612_D6.v1 L4 - https://ndownloader.figshare.com/files/9755818 KW - Gastric cancer KW - Zebrafish KW - Patient-derived xenograft KW - Microinjection KW - Translational research N2 - Toxicity curves for 5-FU, docetaxel, and apatinib. Zebrafish embryos at 72 hpf were treated with increasing concentrations of 5-FU (0–6500 ng/embryo), docetaxel (0–80 μM), and apatinib (0–50 μM) for 2 days. Following 2-day treatment, embryos were examined for viability and teratogenicity. The percentage viability and teratogenicity (for apatinib only) were plotted versus the drug dose. Quantitative values are means ± SEM from 3 replicates. N = 45 embryos at each dose level. (JPEG 125 kb) ER -